Cholera News and Research

Latest Cholera News and Research

Backscattering interferometry can precisely measure membrane protein interactions

A new laser technique has demonstrated that it can measure the interactions between proteins tangled in a cell's membrane and a variety of other biological molecules. These extremely difficult measurements can aid the process of drug discovery.

16 Mar 2011

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has received an offer for funding from a biotech-oriented investment group called BIOTECH Development Partners, LLC.

9 Mar 2011

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Anacor Pharmaceuticals (NASDAQ:ANAC) and the Institute for OneWorld Health (iOWH) today announced the establishment of a joint research agreement to discover antibacterial compounds for treating shigellosis.

8 Mar 2011

Scientist develops cryo-electron microscopy to clarify salmonellae structure

Bacteria like salmonellae infect their host cells by needle-shaped extensions which they create in large numbers during an attack. A group of Vienna-based scientists headed by Thomas Marlovits employed recently developed methods of cryo-electron microscopy and have been able to clarify the structure of this infection apparatus on the near-atomic scale.

4 Mar 2011

OneWorld Health receives FDA clearance for iOWH032 phase 1 trials to treat secretory diarrhea

The Institute for OneWorld Health (iOWH) announced a major milestone in the fight against cholera. The Food and Drug Administration (FDA) granted iOWH permission to begin phase 1 trials for iOWH032, a drug to treat secretory diarrhea. This is the first submission of an Investigational New Drug application for a completely new chemical entity by a non-profit of this size to receive such rapid FDA clearance, and it could be the first synthetic drug of its kind for diarrheal diseases.

2 Mar 2011

Researchers develop new inexpensive way of filtering water with silver nanoparticles

Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.

24 Feb 2011

Haiti's cholera outbreak has plateaued, death rate remains high in rural regions, U.N. says

The U.N. on Friday said Haiti's cholera outbreak appears to be waning overall, but high death rates from the virus in rural regions of the country remain a concern, the Associated Press reports. According to figures released by the Haitian government, 231,070 cholera cases and 4,549 deaths from the disease have been reported since the outbreak first emerged in October.

23 Feb 2011

Johnson & Johnson completes cash tender for Crucell shares, declares offer unconditional

Johnson & Johnson and Crucell N.V. today announce that Johnson & Johnson has completed the tender offer for Crucell N.V. and has declared the offer unconditional.

22 Feb 2011

New research demonstrates how climate change can increase exposure, risk of human illness

A panel of scientists speaking today at the annual meeting of the American Association for the Advancement of Science unveiled new research and models demonstrating how climate change could increase exposure and risk of human illness originating from ocean, coastal and Great Lakes ecosystems, with some studies projecting impacts to be felt within 30 years.

20 Feb 2011

Bangladesh cholera vaccine trial

Bangladesh will conduct the world’s largest clinical trial of an affordable cholera vaccine which could save tens of thousands of lives. The study began Thursday and involves nearly 250,000 people near the capital, Dhaka.

20 Feb 2011

Poll: 73% of New Jersey people think investment on global health research is important to state's economy

Despite the unpredictable economy, nearly three-quarters of New Jersey residents think spending money on research to improve health globally is important to jobs and incomes in the state, according to a new statewide poll commissioned by Research!America.

17 Feb 2011

Upcoming Bangladeshi mass cholera vaccine program might shed light on strategy effectiveness

TIME reports on an oral cholera vaccination program to kick off on Thursday in Bangladesh that researchers hope will determine how good of a "weapon" the mass vaccination strategy can be "against an old disease".

17 Feb 2011

Positive results from Glenmark's crofelemer Phase 2 study in acute watery diarrhea

Napo Pharmaceuticals, Inc. is pleased to announce the positive results of a successfully completed Phase 2 study of crofelemer for the treatment of hospitalized adult patients with mild to moderate acute watery diarrhea conducted by its partner Glenmark Pharmaceuticals Ltd..

14 Feb 2011

New York Times examines factors contributing to presence of 'exotic' infectious diseases in New York City

"When New York City's health department revealed last weekend that three people had contracted cholera, it was a reminder that the city is not just a world capital of arts, business and the like - but also of exotic diseases," the New York Times writes in an article that explores how diseases from around the world often make their way to the city through its diverse population of travelers.

14 Feb 2011

Vaccinating through salivary glands may provide protection against wide range of diseases

If you don't like shots or needles, you're in luck. New research published online in The FASEB Journal gives the development of new oral vaccinations a shot in the arm thanks to discoveries involving the salivary glands of mice. In addition, this research report also offers a tantalizing glimpse of vaccines that could prevent infection at mucosal surfaces, even if direct injections into the body fail to cause immunity. This technique may be effective for a wide range of diseases from influenza to cholera.

11 Feb 2011

Key advance in development of fast, simple test for detection of cholera

With cholera on the rampage in Haiti and almost 40 other countries, scientists are reporting the development of a key advance that could provide a fast, simple test to detect the toxin that causes the disease. The report appears in ACS' journal Bioconjugate Chemistry. Cholera affects more than 200,000 people annually, mainly in developing countries, and causes about 5,000 deaths. Many involve infants, children, and the elderly.

10 Feb 2011

Opinions: Global Fund; Accountability for Haiti Aid

Washington Post columnist Michael Gerson writes of the "breathless Associated Press story" about the uncovering of some corruption in grants given by the Global Fund to Fight AIDS, Tuberculosis and Malaria and the subsequent reaction: "When scandals fit preexisting ideological narratives, they assume a life of their own. This particular narrative - the story of useless, wasted aid - is durable. It is also misleading and might be deadly."

4 Feb 2011

Daily Report Global Health Conversations: Reflections on Haiti's health system

January 12 marked one year since a major earthquake struck Haiti killing hundreds of thousands and significantly damaging its capital city, Port-au-Prince. To learn more about how the quake has affected health care in Haiti and get a sense of health priorities moving forward, Jaclyn Schiff of the Kaiser Daily Global Health Policy Report spoke with Wesler Lambert, a Haitian-born physician who has worked with Partners in Health/Zanmi Lasante since 1997.

2 Feb 2011

U.S. has no plans to end aid to Haiti despite disputed election, Sec. of State Clinton says

During a brief visit to Haiti on Sunday, Secretary of State Hillary Rodham Clinton said the U.S. has no plans to end aid to Haiti despite the unresolved presidential election, the Associated Press/Boston Globe reports (1/31).

1 Feb 2011

European Commission grants approval for Johnson & Johnson's proposed acquisition of Crucell

Johnson & Johnson and Crucell today announced that the European Commission has granted approval for Johnson & Johnson's proposed acquisition of Crucell.

29 Jan 2011

Cholera News and Research

Latest Cholera News and Research

Backscattering interferometry can precisely measure membrane protein interactions

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Scientist develops cryo-electron microscopy to clarify salmonellae structure

OneWorld Health receives FDA clearance for iOWH032 phase 1 trials to treat secretory diarrhea

Researchers develop new inexpensive way of filtering water with silver nanoparticles

Haiti's cholera outbreak has plateaued, death rate remains high in rural regions, U.N. says

Johnson & Johnson completes cash tender for Crucell shares, declares offer unconditional

New research demonstrates how climate change can increase exposure, risk of human illness

Bangladesh cholera vaccine trial

Poll: 73% of New Jersey people think investment on global health research is important to state's economy

Upcoming Bangladeshi mass cholera vaccine program might shed light on strategy effectiveness

Positive results from Glenmark's crofelemer Phase 2 study in acute watery diarrhea

New York Times examines factors contributing to presence of 'exotic' infectious diseases in New York City

Vaccinating through salivary glands may provide protection against wide range of diseases

Key advance in development of fast, simple test for detection of cholera

Opinions: Global Fund; Accountability for Haiti Aid

Daily Report Global Health Conversations: Reflections on Haiti's health system

U.S. has no plans to end aid to Haiti despite disputed election, Sec. of State Clinton says

European Commission grants approval for Johnson & Johnson's proposed acquisition of Crucell

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Cholera News and Research

Latest Cholera News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in